Clinical Research News
-
CMD LLC wins AU$1 million grant award from FightMND
Clinical Research | News | 0 Comment | 18 Apr, 2019
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases. CMD has announced that it w...Read more
-
Zydus Cadila announces phase III trial of Desidustat
Clinical Research | News | 0 Comment | 17 Apr, 2019
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Investigational New Drug targeted at treating anemia in non-dialysis depe...Read more
-
CStone Pharmaceuticals announces dosing in Ph III trial for treating adenocarcinoma
Clinical Research | News | 0 Comment | 16 Apr, 2019
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinical trial assessing CS1001, China's first fully human, full-...Read more
-
CStone receives IND approval in China for avapritinib study
Clinical Research | News | 0 Comment | 15 Apr, 2019
CStone Pharmaceuticals has announced that the National Medical Products Administration (NMPA) recently approved the initiation of a Phase I/II clinical trial in China evaluating a...Read more
-
I-Mab Biopharma collaborates with Roche for combination therapy
Clinical Research | News | 0 Comment | 11 Apr, 2019
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential first-in-class and best-in-class biologics in immuno-oncology and aut...Read more
-
George Clinical establishes new presence in Singapore
Clinical Research | News | 0 Comment | 10 Apr, 2019
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The...Read more
-
NIH begins first-in-human trial of a universal influenza vaccine candidate
Clinical Research | News | 0 Comment | 05 Apr, 2019
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response ...Read more
-
Veeda Clinical Research Achieves ISO 27001:2013 Certification
Clinical Research | News | 0 Comment | 03 Apr, 2019
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has awarded the ISO 27001:2013 Certification to Veeda Clinical Resea...Read more
-
Veeda Clinical Research successfully completes third inspection by NPRA
Clinical Research | News | 0 Comment | 27 Mar, 2019
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and Bioanalytical facilities (Insignia, Ahmedabad) have successfully compl...Read more
-
Eisai starts Phase III clinical trial for Alzheimer's drug
Clinical Research | News | 0 Comment | 25 Mar, 2019
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer's disease...Read more
-
WCG introduces a transformational solution for clinical research sites
Clinical Research | News | 0 Comment | 20 Mar, 2019
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent r...Read more
-
Clinical Research | News | 0 Comment | 18 Mar, 2019
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the National Institutes of Health’s (NIH) National Center for Complementar...Read more
-
Clinical Research | News | 0 Comment | 15 Mar, 2019
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinical study of investigational nifurtimox in pediatric patients with Cha...Read more
-
Alvotech enrolls first patient for Ph III study involving Biosimilar version of HUMIRA
Clinical Research | News | 0 Comment | 14 Mar, 2019
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical study (ALVOPAD PS) involving AVT02, Alvotech's HUMIRA biosimilar can...Read more
-
Kezar Life Sciences to test a new drug formulation of KZR-616
Clinical Research | News | 0 Comment | 07 Mar, 2019
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity...Read more
-
Dr Albers receives the distinguished Clinical Research Achievement Award for stroke research
Clinical Research | News | 0 Comment | 07 Mar, 2019
iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaView co-founder Dr. Gregory Albers has received the highly respected Dis...Read more
-
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial
Clinical Research | News | 0 Comment | 25 Feb, 2019
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more
-
Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer
Clinical Research | News | 0 Comment | 22 Feb, 2019
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced that the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable ...Read more
